Navigation Links
Brinks Hofer Gilson & Lione Expands to High-Tech Raleigh/Durham Area; Adds Accomplished Patent Attorneys to Its New Office
Date:7/9/2008

CHICAGO, July 9 /PRNewswire/ -- Brinks Hofer Gilson & Lione, one of the largest intellectual property law firms in the U.S., announces the opening of a new office in the Raleigh/Durham, North Carolina area and welcomes two local patent attorneys, Allen R. Baum and Joshua T. Elliott, who will be based in the Raleigh office. Mr. Baum and Mr. Elliott, formerly with The Hutchison Law Group, join the firm as partners. The office will officially be open for business on Tuesday, July 15, 2008.

"Brinks is a world leader in intellectual property law and already serves a solid client base in the Research Triangle Park (RTP) region," said Brinks president, Gary M. Ropski. "The addition of these two outstanding attorneys and the new office fits our current practice strategy and addresses an increasing demand from our clients. This expansion into the southeastern United States will allow us to build on our commitment to exceptional service to all clients."

The new Raleigh office will be located in the RTP area, one of the oldest and largest science parks in North America and home to more than 170 companies, including Fortune 100 multinational research organizations, university-based and start-up operations and a number of U.S. federal agencies.

"Josh and I are pleased to practice IP law with such a prominent and respected firm that is dedicated solely to intellectual property," said Mr. Baum. "Brinks offers us the capacity and resources to grow our prosecution practice, as well as expand our litigation service capabilities for clients we currently serve."

"Brinks has established a significant presence in the generic pharmaceutical segment," said Thomas J. Filarski, chair of the firm's Chemical Group and a lead generic pharmaceutical litigator. "The addition of Allen and Josh to our office in Raleigh will markedly enhance the scope of our pharmaceutical, chemical and biotech practice."

Allen R. Baum is a skilled patent attorney focusing his practice in the areas of pharmaceuticals, biochemistry and biotechnology. Prior to and during law school, Mr. Baum was a pharmaceutical chemist for DuPont Merck Pharmaceuticals and SmithKline Beecham. He is a past president of the Licensing Executives Society, an organization of more than 6,000 licensing professionals in the United States and Canada. He also served as the chair of the Chemical/Biotechnology Committee of the North Carolina Bar Association. Mr. Baum received his B.S. from Muhlenberg College, Allentown, PA, and his law degree from Widener University School of Law.

Joshua T. Elliott focuses his practice on patent law matters relating to biochemistry and biotechnology. His clients include technology companies involved in areas such as proteins, peptides, nucleic acids, antibodies, pharmaceuticals, proteomics and RNA interference. Mr. Elliott received his B.S. from the University of North Carolina at Chapel Hill, where he was elected a member of Phi Beta Kappa, and his law degree from the University of Dayton School of Law, where he was a Loren M. Berry Scholar and a member of the University of Dayton Law Review.

Founded in 1917, Brinks Hofer Gilson & Lione is based in Chicago with five other offices across the country serving the intellectual property needs of clients from around the world. The firm is one of the largest IP law firms in the country, with more than 170 attorneys, scientific advisors and patent agents specializing in intellectual property litigation and all aspects of patent, trademark, copyright, trade secret, unfair competition, intellectual asset management, and technology and licensing agreements. Brinks routinely handles assignments in fields as diverse as electrical, chemical, mechanical, biotechnology, pharmaceutical, nanotechnology, Internet and computer technology, as well as in trademarks and brand names for a wide variety of products and services. For additional information, visit http://www.usebrinks.com.

CONTACT:

Sydney Iglitzen

(312) 840-3163

siglitzen@usebrinks.com


'/>"/>
SOURCE Brinks Hofer Gilson & Lione
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Twenty-One Brinks Hofer Gilson & Lione Attorneys Named 2008 Illinois Super Lawyers
2. Fraunhofer and Boston University Hosted Prestigious SME Tour
3. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
4. Yves Lionel Assant is New Chairman of Gerresheimers Supervisory Board
5. SAFC Supply Solutions Expands Halal Offer in Flavors & Fragrances Product Line
6. PAREXEL Expands Global Clinical Logistics Capabilities
7. BioXcel Expands Its Capability in Business Analytics Support Services
8. Corgenix Expands Scientific Advisory Board
9. WuXi PharmaTech (NYSE: WX) Expands Collaboration With AstraZeneca
10. Sunesis Pharmaceuticals Expands Development Leadership Team to Focus on Late-Stage Development of Voreloxin (Formerly SNS-595)
11. Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , the leading software ... Clinical Reach Virtual Patient Encounter CONSULT module which enables both audio and ... clinical trial team. , Using the CONSULT module, patients and physicians can schedule a ...
(Date:6/27/2016)... --  Ginkgo Bioworks , a leading organism design ... awarded as one of the World Economic Forum,s ... innovative companies. Ginkgo Bioworks is engineering biology to ... in the nutrition, health and consumer goods sectors. ... including Fortune 500 companies to design microbes for ...
(Date:6/24/2016)... NC (PRWEB) , ... June 24, 2016 , ... Researchers ... the most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are ... to read it now. , Diagnostic biomarkers are signposts in the blood, lung ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
Breaking Biology Technology:
(Date:6/20/2016)... DALLAS , June 20, 2016 ... criminal justice technology solutions for public safety, investigation, ... by the prisons involved, it has secured the ... Corrections (DOC) facilities for Managed Access Systems (MAS) ... (4) additional facilities to be installed by October, ...
(Date:6/15/2016)... York , June 15, 2016 ... new market report titled "Gesture Recognition Market by Application ... Forecast, 2016 - 2024". According to the report, the  ... 11.60 billion in 2015 and is estimated to ... USD 48.56 billion by 2024.  Increasing ...
(Date:6/9/2016)... 2016 Paris Police Prefecture ... security solution to ensure the safety of people and operations ... the major tournament Teleste, an international technology group ... announced today that its video security solution will be utilised ... up public safety across the country. The system roll-out is ...
Breaking Biology News(10 mins):